China Pharma Holdings, Inc. (NYSE MKT: CPHI) (“China Pharma” or the “Company”), an NYSE MKT listed corporation with its fully-integrated specialty pharmaceuticals subsidiary based in China, today announced financial results for the year ended December 31, 2014. Full Year Highlights Revenue decr…
Source:China Pharma’s revenue decreases 24% to $24.9 million in fiscal year 2014
Tuesday, March 31, 2015
China Pharma’s revenue decreases 24% to $24.9 million in fiscal year 2014
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment